Search filters

List of works by Annamaria Ruzzo

A novel diffuse gastric cancer susceptibility variant in E-cadherin (CDH1) intron 2: a case control study in an Italian population

scientific article

Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer

scientific article published in November 2002

Association of thymidylate synthase polymorphisms with gastric cancer susceptibility

scientific article published in December 2004

Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy

scientific article published on 31 January 2020

Cetuximab plus irinotecan after irinotecan failure in elderly metastatic colorectal cancer patients: clinical outcome according to KRAS and BRAF mutational status.

scientific article published on 8 July 2010

Clinical impact of the HGF/MET pathway activation in patients with advanced gastric cancer treated with palliative chemotherapy

scientific article published on 25 March 2014

Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs.

scientific article published in March 2004

Endogastric capsule for E-cadherin gene (CDH1) promoter hypermethylation assessment in DNA from gastric juice of diffuse gastric cancer patients

scientific article published on 06 November 2007

Gender effects of single nucleotide polymorphisms and miRNAs targeting clock-genes in metastatic colorectal cancer patients (mCRC)

scientific article published on 26 September 2016

Genetic activation of the MET pathway and prognosis of patients with high-risk, radically resected gastric cancer.

scientific article published on 31 October 2011

Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients

scientific article

Genetic modulation of the Let-7 microRNA binding to KRAS 3'-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan

scientific article

Genetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy.

scientific article

Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer.

scientific article published in March 2016

Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab

scientific article published on 05 May 2020

High concordance of BRAF status between primary colorectal tumours and related metastatic sites: implications for clinical practice

scientific article published on 01 July 2010

High concordance of KRAS status between primary colorectal tumors and related metastatic sites: implications for clinical practice

scientific article published on 04 December 2008

High let-7a microRNA levels in KRAS-mutated colorectal carcinomas may rescue anti-EGFR therapy effects in patients with chemotherapy-refractory metastatic disease

scientific article

High resolution melting (HRM) analysis for the detection of ER22/23EK, BclI, and N363S polymorphisms of the glucocorticoid receptor gene.

scientific article

Host genetic variants in the IGF binding protein-3 impact on survival of patients with advanced gastric cancer treated with palliative chemotherapy.

scientific article published in September 2010

Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype.

scientific article

Interleukin 1beta-511T gene (IL1beta) polymorphism is correlated with gastric cancer in the Caucasian population: results from a meta-analysis

scientific article published in November 2008

Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer

article

KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer.

scientific article published on 14 July 2009

Linkage disequilibrium for DNA haplotypes near the cystic fibrosis locus in two south European populations

scientific article published in September 1989

MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma.

scientific article published on 07 December 2016

Methylenetetrahydrofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at-risk Italian population.

scientific article published in February 2006

Molecular analysis of G6PD variants in northern Italy: a study on the population from the Ferrara district

scientific article published on 01 September 1993

Molecular predictors of efficacy to anti-EGFR agents in colorectal cancer patients.

scientific article published on February 2010

NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population.

scientific article published on 4 May 2009

PML as a potential predictive factor of oxaliplatin/fluoropyrimidine-based first line chemotherapy efficacy in colorectal cancer patients

scientific article published on 01 March 2012

PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancer.

scientific article published on 27 April 2009

Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy

scientific article published on 01 April 2006

Pharmacogenetic profiling for cetuximab plus irinotecan therapy in patients with refractory advanced colorectal cancer

scientific article

Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy

scientific article published on 01 April 2007

Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer

scientific article published on 01 January 2007

Predictive and prognostic role of E-cadherin protein expression in patients with advanced gastric carcinomas treated with palliative chemotherapy.

scientific article published in May 2004

Predictors of benefit in colorectal cancer treated with cetuximab: are we getting "Lost in TranslationAL"?

scientific article published on 22 February 2010

Prognostic Role ofInterleukin-1βGene andInterleukin-1 Receptor AntagonistGene Polymorphisms in Patients With Advanced Gastric Cancer

article

Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer.

scientific article published on April 2004

Prognostic role of thymidylate synthase polymorphisms in gastric cancer patients treated with surgery and adjuvant chemotherapy

scientific article published on 01 May 2005

Prospective study of EGFR intron 1 (CA)n repeats variants as predictors of benefit from cetuximab and irinotecan in chemo-refractory metastatic colorectal cancer (mCRC) patients

scientific article

Prospective validation of candidate SNPs of VEGF/VEGFR pathway in metastatic colorectal cancer patients treated with first-line FOLFIRI plus bevacizumab

scientific article

Reply: KRAS status analysis and anti-EGFR therapies: is comprehensiveness a biologist's fancy or a clinical necessity?

scientific article published on 16 February 2010

Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer

scientific article

Role of KRAS let-7 LCS6 SNP in metastatic colorectal cancer patients

scientific article

Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapy.

scientific article

Role of the interleukin-1 receptor antagonist gene polymorphism (IL-1RN*2) in early gastric cancer

scientific article published on 01 August 2005

Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy

scientific article published on 08 August 2019

Should oncologists be aware in their clinical practice of KRAS molecular analysis?

scientific article

TP53 Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard Chemotherapy

scientific article published on 24 July 2020

The G/A nucleotide change at cDNA position 2494 in the E-cadherin gene (CDH1): analysis in Italian patients

scientific article published on 01 May 2003

VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population.

scientific article

Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer

scientific article published on 23 December 2008

Paulina is supported by:

About Paulina

Help